9 Million

Global
Potential Patients

6.3 Million

Potential Patients in Africa

$4.0
Billion / Year

Total Available Market (TAM)

in Africa

IMCI has the opportunity to be the first one to develop and introduce new pharmaceutical, patented, and effective cannabinoid-based treatments to treat
a specific neuropathic health condition.

Contact Us

We welcome questions regarding our company.
You can reach us by filling out the contact form below or through email.

Main Office: Keizersgracht 391 A, 1016 Amsterdam, Netherland

Regional Offices:

Israle: Gan Yavne, Israel

South Africa: Johannesburg, South Africa

  • LinkedIn
arrow&v

© 2020 by IMCI Pharmaceuticals